Dr. Hillson has served as our Senior Vice President, Drug Development since November 2016, bringing two decades experience in academic rheumatology research, patient care and teaching and more than a decade directing strategy and operations related to clinical research and translational medicine within our industry. From 2013 to 2016, Dr. Hillson served as Vice President of Clinical and Translational Research at Momenta Pharmaceuticals; from 2007 to 2013 she served as Senior Director at ZymoGenetics/Bristol Myers Squibb, leading Clinical Research and Pharmacology for projects in immunology and immuno-virology. Prior to 2007, Dr. Hillson served in several positions, including Medical Director at Xcyte Therapies, Clinical Faculty at Harvard Medical School (Cambridge Health Alliance), Assistant Professor at University of Washington, and Division Head at Virginia Mason Medical Center providing consultative and direct patient care, with a sub-specialty in uncommon autoimmune diseases, including vasculitis, systemic lupus, scleroderma and myositis. Dr. Hillson received her M.D. from Stanford School of Medicine, an M.S. from the California Institute of Technology and Scripps Institute of Oceanography, and a B.S. from Michigan State University.